TULANE CANCER GENETICS COBRE: CELL ASSAY CORE
TULANE CANCER GENETICS COBRE: CELL ASSAY CORE
批准号:
7720773
负责人:
ERIK K FLEMINGTON
金额:
$14.89万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2009-07-31
关键词:
Biological AssayCellsComputer Retrieval of Information on Scientific Projects DatabaseDevicesEquipmentFloorFundingGenetic ResearchGrantInstitutionMutagenesisResearchResearch PersonnelResourcesScientistSeriesSourceThinkingUnited States National Institutes of Healthbasecancer geneticsconceptdesignexperiencegene functionprograms
中文摘要
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This Core is designed to fill the specific needs of our PJIs and other Programmatic scientists that are not covered by the other Cores described above. We think of it as our particular Programmatic Core that will support the Cancer Genetics floor in the new LCRC building. The concept for this CORE was developed by the LCRC Genetics Research Program in discussions over the last year. This CORE will have an experienced technician to carry out assays and operate equipment optimally. The equipment will involve a series of devices utilized in cell-based assays for gene function, expression and mutagenesis assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
-
批准号:10647826
-
项目类别:
-
资助金额:$41.28万
-
财政年份:2022
-
负责人:ERIK K FLEMINGTON
-
依托单位:
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
-
批准号:10548370
-
项目类别:
-
资助金额:$42.13万
-
财政年份:2022
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Programmed splicing derangement as new EBV host cell shut-off mechanism
-
批准号:10580068
-
项目类别:
-
资助金额:$41.79万
-
财政年份:2022
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Programmed splicing derangement as new EBV host cell shut-off mechanism
-
批准号:10446536
-
项目类别:
-
资助金额:$42.65万
-
财政年份:2022
-
负责人:ERIK K FLEMINGTON
-
依托单位:
RPMS1 circular RNAs in EBV malignancies
-
批准号:10397562
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2019
-
负责人:ERIK K FLEMINGTON
-
依托单位:
RPMS1 circular RNAs in EBV malignancies
-
批准号:10612751
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2019
-
负责人:ERIK K FLEMINGTON
-
依托单位:
RPMS1 circular RNAs in EBV malignancies
-
批准号:10153734
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2019
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Project 2: Joint Transcriptomic and Epigenomic Studies for Male Osteoporosis
-
批准号:10180819
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2017
-
负责人:ERIK K FLEMINGTON
-
依托单位:
"Core B" Viral RNA-seq and bioinformatics Core
-
批准号:10403019
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2017
-
负责人:ERIK K FLEMINGTON
-
依托单位:
"Core B" Viral RNA-seq and bioinformatics Core
-
批准号:10646252
-
项目类别:
-
资助金额:$16.28万
-
财政年份:2017
-
负责人:ERIK K FLEMINGTON
-
依托单位:
"Project 2" Microprocessor overload in gamma-herpesviral oncogenesis
-
批准号:10403016
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2017
-
负责人:ERIK K FLEMINGTON
-
依托单位:
"Project 2" Microprocessor overload in gamma-herpesviral oncogenesis
-
批准号:10646232
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2017
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Epstein Barr virus antisense transcription
-
批准号:9206435
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2014
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Epstein Barr virus antisense transcription
-
批准号:8750146
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2014
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Intercellular communication in Epstein Barr virus reactivation
-
批准号:8820881
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2012
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Intercellular communication in Epstein Barr virus reactivation
-
批准号:8341401
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2012
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Intercellular communication in Epstein Barr virus reactivation
-
批准号:9035348
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2012
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Intercellular communication in Epstein Barr virus reactivation
-
批准号:8458081
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2012
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Intercellular communication in Epstein Barr virus reactivation
-
批准号:8639468
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2012
-
负责人:ERIK K FLEMINGTON
-
依托单位:
Role of the cellular microRNA, miR-155, in EBV type III latency signaling
-
批准号:8455707
-
项目类别:
-
资助金额:$28.19万
-
财政年份:2009
-
负责人:ERIK K FLEMINGTON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: